Glaucoma

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, shares data on an aceclidine-based presbyopia-correcting eye drop from Lenz Therapeutics.

KOLOA, Hawaii — Measuring an eye for an ICL requires the right technology and formulas, according to a speaker at Hawaiian Eye 2025.

Adam Szaronos has been appointed as CEO of Iantrek, succeeding Sean Ianchulev, MD, MPH, according to a press release.

Among patients with suspected or confirmed glaucoma, higher average blood pressure and greater variability in blood pressure were associated with faster visual field loss, according to a study published in JAMA Ophthalmology.

KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here at Hawaiian Eye 2025.

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.

OCT angiography alone demonstrated superior sensitivity in detecting glaucomatous changes in the optic disc and macula compared with OCT and OCT angiography combined, according to a study published in Clinical Ophthalmology.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.

The Paul Glaucoma Implant, a novel glaucoma drainage device, safely and effectively managed uveitic glaucoma in children and adults, according to an analysis of midterm results published in Eye.

Resveratrol supplementation with selective laser trabeculoplasty may be an effective treatment option for glaucoma by reducing IOP and offering neuroprotective benefits, according to a paper published in Open Journal of Ophthalmology.